Akebia Therapeutics Inc
SWB:AX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akebia Therapeutics Inc
SWB:AX9
|
US |
|
T
|
Tesla Inc
XMUN:TL0
|
US |
|
S
|
Swisscom AG
XBER:SWJA
|
CH |
|
Crane Co
F:T12
|
US |
|
A
|
ACS Actividades de Construccion y Servicios SA
XMUN:OCI1
|
ES |
|
D
|
DaVita Inc
XBER:TRL
|
US |
|
C
|
China Telecom Corp Ltd
XMUN:ZCH
|
CN |
|
T
|
Thermo Fisher Scientific Inc
BMV:TMO
|
US |
|
G
|
Gap Inc
XBER:GAP
|
US |
|
C
|
Continental AG
MIL:CON
|
DE |
|
International Paper Co
LSE:IPC
|
US |
|
E
|
Exelon Corp
F:PEO
|
US |
|
M
|
Mercadolibre Inc
XBER:MLB1
|
AR |
|
H
|
Hochtief AG
F:HOT
|
DE |
|
O
|
Oracle Corp
DUS:ORC
|
US |
|
M
|
Murray & Roberts Holdings Ltd
SWB:LDYA
|
ZA |
|
I
|
Iniziative Bresciane Inbre SpA
MIL:IB
|
IT |
|
Japan Tobacco Inc
F:JAT
|
JP |
|
G
|
Gartner Inc
LSE:0ITV
|
US |
|
A
|
Autozone Inc
F:AZ5
|
US |
|
V
|
Vodafone Group PLC
NASDAQ:VOD
|
UK |
|
Opthea Ltd
F:UKJ2
|
AU |
|
A
|
ABOUT YOU Holding SE
F:YOU
|
DE |
|
A
|
Airtel Africa PLC
XBER:9AA
|
UK |
Shareholder Yield
Current shareholder yield for 
AX9 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AX9 Price
Akebia Therapeutics Inc
| Average Annual Return | 20.87% |
| Standard Deviation of Annual Returns | 84.07% |
| Max Drawdown | -94% |
| Market Capitalization | 307.9m EUR |
| Shares Outstanding | 333 020 897 |
| Percentage of Shares Shorted |
N/A
|
